Standard
Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA’s and FDA’s Views on Initial Dual-Therapy. / Bjerrum, Ole Jannik; Eichendorff, Sascha; Alkis, Nada Bassam.
I:
Therapeutic Innovation & Regulatory Science, 2019.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Bjerrum, OJ, Eichendorff, S & Alkis, NB 2019, '
Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA’s and FDA’s Views on Initial Dual-Therapy',
Therapeutic Innovation & Regulatory Science.
https://doi.org/10.1177/2168479019836976
APA
Bjerrum, O. J., Eichendorff, S., & Alkis, N. B. (2019).
Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA’s and FDA’s Views on Initial Dual-Therapy.
Therapeutic Innovation & Regulatory Science.
https://doi.org/10.1177/2168479019836976
Vancouver
Bjerrum OJ, Eichendorff S, Alkis NB.
Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA’s and FDA’s Views on Initial Dual-Therapy.
Therapeutic Innovation & Regulatory Science. 2019.
https://doi.org/10.1177/2168479019836976
Author
Bjerrum, Ole Jannik ; Eichendorff, Sascha ; Alkis, Nada Bassam. / Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA’s and FDA’s Views on Initial Dual-Therapy. I: Therapeutic Innovation & Regulatory Science. 2019.
Bibtex
@article{fe1828b9157240869f69c50f96b0d07b,
title = "Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA{\textquoteright}s and FDA{\textquoteright}s Views on Initial Dual-Therapy",
author = "Bjerrum, {Ole Jannik} and Sascha Eichendorff and Alkis, {Nada Bassam}",
year = "2019",
doi = "10.1177/2168479019836976",
language = "English",
journal = "Therapeutic Innovation & Regulatory Science",
issn = "2168-4790",
publisher = "SAGE Publications",
}
RIS
TY - JOUR
T1 - Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA’s and FDA’s Views on Initial Dual-Therapy
AU - Bjerrum, Ole Jannik
AU - Eichendorff, Sascha
AU - Alkis, Nada Bassam
PY - 2019
Y1 - 2019
U2 - 10.1177/2168479019836976
DO - 10.1177/2168479019836976
M3 - Journal article
JO - Therapeutic Innovation & Regulatory Science
JF - Therapeutic Innovation & Regulatory Science
SN - 2168-4790
ER -
